BeiGene

IPO

One World. One Goal.

BeiGene is a biotech company in Cambridge, United States, founded in 2010. It has raised $2.8B across 1 round, most recently a $2.8B Corporate Round in January 2020.

Employees
10001+
Founded
2010
Business Model
B2B
Total Funding
$2.8B
Last Round
$2.8B Corporate RoundJan 2020
Rounds
1
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 3 investors for this company. to use credits for reveals, or explore the API.

About

BeOne Medicines (formerly BeiGene) is a global oncology company committed to discovering and developing innovative treatments to make a meaningful difference for cancer patients worldwide. With a portfolio of approved medicines across hematologic and solid tumor cancers including BTK inhibitors and anti-PD-1 therapies, BeOne operates research facilities and commercial operations in over 45 countries. The company completed its rebrand from BeiGene to BeOne Medicines in 2025.

Funding & Exit History

Data from Indexed.vcUpdated
IPODec 2021
$3.5B

4 more events

  • Secondary Market2020
  • Corporate Round20201 investor
  • IPO2018

Funding: Corporate Round. Amounts, valuations, and investors where available.

Investors

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

  • Backend ×1
  • Cloud/Infrastructure ×1
  • Marketing & SEO ×1

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Companies in related industries

Avenzo

Avenzo is a San Diego, CA-based biopharma company to in-license and develop the next generation o...

San Diego, United States1–10Biotech
Series BTotal funding$832.0MSep 2025
Bicycle TherapeuticsIPO

Novel bicyclic peptides and drug conjugates for cancer

Cambridge, United States201–500Biotech
Private EquityTotal funding$607.0MJan 2024
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Biotech
Series ATotal funding$3.0BJan 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

BeiGene on Indexed.vc
<a href="https://indexed.vc/companies/beigene"><img src="https://indexed.vc/api/badge/company/beigene" alt="BeiGene on Indexed.vc" width="260" height="76" /></a>